image
MannKind Corporation MNKD
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.8
-3.13 %
$ 1.88 B
Market Cap
85.0
P/E
CASH FLOW STATEMENT
34.1 M OPERATING CASH FLOW
142.26%
Growth Rates
1Year 142.26%
3Years 47.55%
5Years 23.76%
7Years 13.57%
10Years 8.52%
-1.99 M INVESTING CASH FLOW
-40.79%
Growth Rates
1Year -40.79%
3Years -4.18%
5Years -53.41%
7Years -8.45%
10Years 12.98%
137 M FINANCING CASH FLOW
538.17%
Growth Rates
1Year 538.17%
3Years 39.94%
5Years 17.38%
7Years 17.94%
10Years -0.64%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis MannKind Corporation
image
Net Income -11.9 M
Depreciation & Amortization 5.84 M
Capital Expenditures -42.4 M
Stock-Based Compensation 17.6 M
Change in Working Capital 14.6 M
Others 17.1 M
Free Cash Flow -8.35 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002
OPERATING CASH FLOW
Net Income (11.9) (87.4) (80.9) (57.2) (51.9) (87.0) (117.3) 125.7 (368.4) (198.4) (191.5) (169.4) (160.8) (170.6) (220.1) (303.0) (293.2) (230.5) (114.3) (76.0) (65.9) (206.3)
Depreciation & Amortization 5.8 9.1 5.5 3.3 2.2 1.7 3.5 4.2 13.3 18.6 14.1 14.4 15.9 17.3 18.7 12.3 9.0 8.5 7.4 7.2 7.7 5.1
Deferred Income Tax 0 0 12.6 10.7 (4.6) 0 12.9 (79.6) 180.4 1.5 0.8 2.0 160.8 0.6 12.9 0.2 (10.6) (14.6) 0 (4.5) 0 0
Stock Based Compensation 17.6 13.4 12.2 6.5 6.2 6.9 4.8 5.1 8.7 48.6 45.2 13.3 11.2 13.6 20.2 24.8 17.6 14.7 0 4.5 0 0
Other Operating Activities 7.9 8.2 6.6 18.4 (28.0) 5.7 3.7 5.8 67.8 10 K 2 K 6.5 (160.8) 6 K 7 K (0.2) 18.6 16.9 (1.9) 7.3 7.3 151.6
Change in Working Capital 14.6 (24.1) (17.7) (9.8) (12.4) 36.7 27.6 (139.3) 41.0 133.8 2.7 13.3 9.9 (9.6) (15.8) (5.3) 13.4 15.2 7.6 1.6 (1.9) 0.9
Cash From Operations 34.1 (80.7) (61.7) (28.1) (88.5) (37.7) (64.8) (78.1) (57.2) 4.1 (128.7) (119.9) (123.8) (148.7) (184.1) (271.3) (245.1) (189.8) (101.2) (59.9) (52.8) (48.7)
INVESTING CASH FLOW
Capital Expenditures (42.4) (7.6) (11.5) (4.8) (2.6) (0.4) 0 (1.1) (10.3) (24.1) (8.0) (0.6) (6.9) (9.5) (18.9) (82.5) (78.3) (20.8) (17.2) (6.9) (5.2) (34.1)
Other Items 40.5 12.5 (140.1) 20.0 (20.3) 0.1 16.7 17 K 82 K 0 0 77 K 3.9 (2.2) 15.8 (17.5) 116.9 (27.5) (77.2) (2.7) 9.3 (11.2)
Cash From Investing Activities (2.0) 4.9 (151.5) 15.2 (22.8) (0.2) 16.7 (1.1) (10.2) (24.1) (8.0) (0.6) (2.9) (11.7) (3.1) (99.9) 38.7 (48.3) (94.4) (9.6) 4.1 (45.3)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 (26.9) 0 0 0 0 0 0 0 0 0 0 (1.0) 0
Total Debt Repaid (6.9) 18 K 281.1 14.9 63.7 (5.0) 15.4 (5.0) (64.3) 60.0 4.5 12.8 53.0 182.8 135.0 30.0 0 111.3 0 0 1.4 24 K
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 136.6 4.4 (12.7) 11.3 3.0 (4.2) (3.4) (2.9) 1.3 (2.3) 87.6 (0.9) (0.5) (3.4) (7.0) (0.3) (0.5) (0.3) 0 16.7 31.8 1.3
Cash From Financing Activities 136.6 21.4 270.3 49.9 69.9 61.3 73.6 43.0 5.7 70.1 145.7 179.6 63.4 196.4 189.5 30.6 255.2 501.6 172.7 101.5 82.8 60.2
CHANGE IN CASH
Net Change In Cash 168.7 (54.4) 57.0 36.9 (41.5) 23.3 25.5 (36.2) (61.8) 50.1 8.9 59.2 (63.4) 36.0 2.4 (340.6) 48.7 263.5 (22.9) 32.0 34.2 (33.8)
FREE CASH FLOW
Free Cash Flow (8.3) (88.3) (73.2) (32.9) (91.0) (38.1) (64.8) (79.2) (67.5) (20.0) (136.7) (120.5) (130.7) (158.2) (202.9) (353.7) (323.4) (210.6) (118.4) (66.8) (58.0) (82.8)